Tbio CHN2 Beta-chimaerin

Protein Summary

Description

GTPase-activating protein for p21-rac. Insufficient expression of beta-2 chimaerin is expected to lead to higher Rac activity and could therefore play a role in the progression from low-grade to high-grade tumors. This gene encodes a guanosine triphosphate (GTP)-metabolizing protein that contains a phorbol-ester/diacylglycerol (DAG)-type zinc finger, a Rho-GAP domain, and an SH2 domain. The encoded protein translocates from the cytosol to the Golgi apparatus membrane upon binding by diacylglycerol (DAG). Activity of this protein is important in cell proliferation and migration, and expression changes in this gene have been detected in cancers. A mutation in this gene has also been associated with schizophrenia in men. Alternative transcript splicing and the use of alternative promoters results in multiple transcript variants. [provided by RefSeq, May 2014]

Uniprot Accession IDs

• P52757
• A4D1A2
• B3VCF1
• B3VCF2
• B3VCF3
• B3VCF7
• B3VCG1
• C9J7B0
• E9PGE0
• F8QPL9
• Q2M203
• Q75MM2

Gene Name

• CHN2

Ensembl ID

• ENST00000222792
• ENSP00000222792
• ENSG00000106069
• ENST00000412711
• ENSP00000486515
• ENST00000421775
• ENSP00000394284

Symbol

• ARHGAP3
• BCH
• BCH
• CHN2-3
• ARHGAP3
• RHOGAP3

Knowledge Table

Most Knowledge About	Knowledge Value (0 to 1 scale)
trait	1
protein domain	0.85
kinase perturbation	0.84
PubMedID	0.73
transcription factor	0.73

Protein Classes

No PANTHER Classes or DTO Classes found

IDG Development Level Summary

Tdark

These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 104.21   (req: < 5)

Gene RIFs: 24   (req: <= 3)

Antibodies: 225   (req: <= 50)

Tbio

These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:

Pubmed score: 104.21   (req: >= 5)

Gene RIFs: 24   (req: > 3)

Antibodies: 225   (req: > 50)

- OR - satisfy the following criterion:

Gene Ontology Terms: 5

Tchem

Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions

Active Ligand: 0

Tclin

Target has at least one approved drug - AND - satisfies the preceding conditions

Active Drug: 0